Congenital extrahepatic portosystemic shunt (Abernethy malformation) treated endovascularly with vascular plug shunt closure

2011 ◽  
Vol 28 (1) ◽  
pp. 79-83 ◽  
Author(s):  
Matthew Passalacqua ◽  
Kevin T. Lie ◽  
Hooman Yarmohammadi
2019 ◽  
Vol 25 (3) ◽  
pp. 230-232
Author(s):  
Mehmet Nur Kaya ◽  
◽  
Omer Toprak ◽  
Sultan Turel ◽  
Ugur Ergun ◽  
...  

2019 ◽  
Vol 3 ◽  
pp. 9
Author(s):  
Nainesh Parikh ◽  
Kun Jiang ◽  
Kim Truong

A 45-year-old man with incidentally discovered, unresectable HCC were treated with TACE to the left hepatic lobe and TARE to the right hepatic lobe. Upon retrospective review, he was found to have a congenital extrahepatic portosystemic shunt with the absence of the portal vein (Abernethy malformation). This case report discusses variant splanchnic and portal anatomy in the setting of rare, congenital portosystemic shunts and evaluates types of liver-directed therapies for HCC in this setting.


2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Jonathan K. Park ◽  
Sung-Ki Cho ◽  
Stephen Kee ◽  
Edward W. Lee

While balloon-assisted retrograde transvenous obliteration (BRTO) has been used for two decades in Asia for the management of gastric variceal bleeding, it is still an emerging therapy elsewhere. Given the shunt closure brought about by the procedure, BRTO has also been used for the management of portosystemic encephalopathy with promising results. Modified versions of BRTO have been developed, including plug-assisted retrograde transvenous obliteration (PARTO), where a vascular plug is deployed within a portosystemic shunt. To our knowledge, we present the first North American case of PARTO in the setting of a large splenorenal shunt for the management of portosystemic encephalopathy.


Sign in / Sign up

Export Citation Format

Share Document